Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and Hypercholesterolemia

oxazoles has been researched along with Hypercholesterolemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aragoncillo, P; Cachofeiro, V; Cediel, E; de las Heras, N; Lahera, V; Oubiña, MP; Sanz-Rosa, D1
Bujo, H; Hashimoto, N; Jiang, M; Saito, Y; Seki, N; Shibasaki, M; Takahashi, K1
Kordella, T1
Beucler, I; Dairou, F; Février, B; Scemama, M1
Aragoncillo, P; Cachofeiro, V; Cediel, E; de Las Heras, N; Díaz, C; Hernández, G; Lahera, V; Navarro-Cid, J; Ruilope, LM; Sanz-Rosa, D; Vázquez-Pérez, S1

Trials

1 trial(s) available for oxazoles and Hypercholesterolemia

ArticleYear
[Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Annales de cardiologie et d'angeiologie, 1996, Volume: 45, Issue:10

    Topics: Antihypertensive Agents; Captopril; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Lipids; Male; Middle Aged; Oxazoles; Rilmenidine; Time Factors

1996

Other Studies

4 other study(ies) available for oxazoles and Hypercholesterolemia

ArticleYear
Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits.
    Clinical science (London, England : 1979), 2003, Volume: 104, Issue:4

    Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Bridged Bicyclo Compounds, Heterocyclic; Diet; Endothelium, Vascular; Enzyme Inhibitors; Fibrinolysis; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; In Vitro Techniques; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxazoles; Plasminogen Activator Inhibitor 1; Rabbits; Thromboxane A2; Tissue Plasminogen Activator; Vasoconstrictor Agents

2003
A potent activator of PPARalpha and gamma reduces the vascular cell recruitment and inhibits the intimal thickning in hypercholesterolemic rabbits.
    Atherosclerosis, 2005, Volume: 178, Issue:1

    Topics: Animals; Blood Vessels; Butyrates; Carotid Arteries; Cell Adhesion; Cell Division; Cell Movement; Cells, Cultured; Chemokine CCL2; Endothelial Cells; Humans; Hypercholesterolemia; Hyperplasia; Macrophages; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxazoles; PPAR alpha; PPAR gamma; Rabbits; Tunica Intima

2005
One pill, two conditions.
    Diabetes forecast, 2005, Volume: 58, Issue:10

    Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glycine; Humans; Hypercholesterolemia; Oxazoles; United States

2005
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1

    Topics: Acetylcholine; Animals; Anticholesteremic Agents; Atorvastatin; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hypercholesterolemia; Kidney; Male; Nitroprusside; Oxazoles; Phenylephrine; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Renal Circulation; Vasodilation

2001